Procurement Summary
Country: USA
Summary: Agilent Tape Station Service Contract
Deadline: 28 Jul 2026
Posting Date: 25 Jul 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 145884487
Document Ref. No.: 2026-Q-97416
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
The Center for Disease Control and Prevention (CDC), National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) International Laboratory Branch intends to award a firm-fixed price, sole source purchase order to Agilent Technologies, Inc., 2850 Centerville Rd, Wilmington, Delware 19808-1610 for the purchase of an annual service agreement.
The authority for this sole source acquisition is in accordance with FAR Part 5.201 and FAR Part 12.102(a).
The Agilent TapeStation Instrument currently utilized by National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) International Laboratory Branch contains highly specialized and proprietary technical capabilities developed exclusively by Agilent Technologies, the Original Equipment Manufacturer (OEM). Agilent Technologies retains exclusive rights to the technical data, internal schematics, and specialized diagnostic software required to properly service, troubleshoot, and maintain this equipment. No third-party vendors possess the authorized diagnostic tools, proprietary software patches, or OEM-certified replacement parts necessary to perform this work. Furthermore, utilizing a non-OEM certified technician would compromise the integrity of the system and void existing manufacturer warranties. Therefore, Agilent Technologies is the only source reasonably available to satisfy the government's requirement without causing severe operational delays or technical risk."
This notice is not a request for competitive quotes, and a formal solicitation will not be issued publicly. However, any responsible source that believes it can fulfill this requirement may submit a comprehensive capability statement. Responses must include written verifiable proof of explicit authorization from the OEM to service this specific equipment model line, access to proprietary OEM diagnostics, and immediate access to genuine OEM parts. Generic capability statements that do not explicitly address these proprietary ...
Notice ID: 2026-q-97416
Department/Ind. Agency: health and human services, department of
Sub-tier: centers for disease control and prevention
Office: cdc office of acquisition services
Product Service Code: j066 - maint/repair/rebuild of equipment- instruments and laboratory equipment
NAICS Code: 334516 - Analytical Laboratory Instrument Manufacturing
Inactive Dates: aug 12, 2026
Inactive Policy: 15 days after date offers due
Documents
Tender Notice
Documents.zip